Finance

Lists
Why is 000513 up 3.18%?
Dive Deeper
000513:SHE
Livzon Pharmaceutical Group Inc
CN¥28.52
+3.18%
(+0.88) 1D
Oct 30, 3:04:18 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000513...
Open
CN¥27.67
High
CN¥28.96
Low
CN¥27.20
Mkt. cap
22.67B
Avg. vol.
14.24M
Volume
17.52M
Dividend
6.08%
Quarterly dividend
CN¥0.43
Ex-dividend date
Oct 14, 2026
P/E ratio
16.26
52-wk high
CN¥37.85
52-wk low
CN¥25.70
EPS
CN¥1.75
Shares outstanding
588.10M
No. of employees
9K
Open
CN¥27.67
High
CN¥28.96
Low
CN¥27.20
Mkt. cap
22.67B
Avg. vol.
14.24M
Volume
17.52M
Dividend
6.08%
Quarterly dividend
CN¥0.43
Ex-dividend date
Oct 14, 2026
P/E ratio
16.26
52-wk high
CN¥37.85
52-wk low
CN¥25.70
EPS
CN¥1.75
Shares outstanding
588.10M
No. of employees
9K
News stories
From web sources and news partners
About Livzon Pharmaceutical Group Inc
CEO-
Employees8.88K
FoundedJan 26, 1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.90B
2.87B
2.13B
2.32B
Cost of goods sold
1.07B
979.89M
954.72M
975.34M
Cost of revenue
1.07B
979.89M
954.72M
975.34M
Research and development expenses
254.68M
169.43M
188.59M
205.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13B
868.91M
548.97M
704.13M
Operating expense
1.50B
1.06B
779.85M
883.77M
Total operating expenses
2.57B
2.04B
1.73B
1.86B
Operating income
337.97M
835.51M
394.17M
460.53M
Other non operating income
3.78M
-23.80M
22.57M
-64.25M
EBT including unusual items
365.51M
851.71M
474.33M
506.91M
EBT excluding unusual items
362.05M
871.56M
430.85M
571.61M
Income tax expense
84.72M
127.70M
77.42M
75.59M
Effective tax rate
23.18%
14.99%
16.32%
14.91%
Other operating expenses
121.57M
18.39M
39.13M
-25.58M
Net income
269.15M
576.91M
355.29M
355.91M
Net profit margin
9.27%
20.09%
16.69%
15.34%
Earnings per share
-
-
-
-
Interest and investment income
56.74M
69.53M
64.60M
146.30M
Interest expense
-13.51M
-9.68M
-12.11M
-9.33M
Net interest expenses
43.23M
59.85M
52.48M
136.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
474.48M
972.03M
533.65M
597.04M
Gain or loss from assets sale
3.21M
-
523.14K
-523.14K
Upcoming events
AI content may include mistakes. Learn more
Google apps